Ledger.Open graph →
SEC Form D · filed May 23, 2024

Lycia Therapeutics, Inc

Offering
$106.6M
Sold
$106.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

William Rieflin · New York, NYDirectorClare Ozawa · SAN DIEGO, CADirectorAetna Wun Trombley · South San Francisco, CAExec · DirectorMing Fang · Baltimore, MDDirectorLaurent Fischer · Princeton, NJDirectorTim Anderson · South San Francisco, CADirectorAndrew Gottesdiener · South San Francisco, CADirectorMing Fang · Baltimore, MDDirectorLaurent Fischer · South San Francisco, CADirectorTim Anderson · South San Francisco, CADirectorAndrew Gottesdiener · South San Francisco, CADirectorWilliam Rieflin · New York, NYDirectorClare Ozawa · SAN DIEGO, CADirectorAetna Wun Trombley · South San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗